Suppr超能文献

交沙霉素和蔷薇霉素:与红霉素和克林霉素的体外比较

Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.

作者信息

Shadomy S, Tipple M, Paxton L

出版信息

Antimicrob Agents Chemother. 1976 Oct;10(4):773-5. doi: 10.1128/AAC.10.4.773.

Abstract

The macrolide antibiotics josamycin and rosamicin were compared in vitro with erythromycin for activity against Staphylococcus aureus, S. epidermidis, and enterococci and with clindamycin for activity against a variety of anaerobic organisms. Rosamicin and erythromycin were similar in activity and superior to josamycin against aerobic cocci. Most isolates of S. aureus (96%), S. epidermidis (79%), and the enterococci (87%) were inhibited by 1.56 mug of either of the new macrolide compounds per ml. Clindamycin was the most active compound against the anaerobic organisms.

摘要

将大环内酯类抗生素交沙霉素和蔷薇霉素在体外与红霉素进行比较,以观察其对金黄色葡萄球菌、表皮葡萄球菌和肠球菌的活性,并与克林霉素比较其对多种厌氧菌的活性。蔷薇霉素和红霉素活性相似,且在抗需氧球菌方面优于交沙霉素。每毫升含1.56微克这两种新大环内酯类化合物中的任何一种,就能抑制大多数金黄色葡萄球菌(96%)、表皮葡萄球菌(79%)和肠球菌(87%)分离株。克林霉素是对厌氧菌活性最强的化合物。

相似文献

1
Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Antimicrob Agents Chemother. 1976 Oct;10(4):773-5. doi: 10.1128/AAC.10.4.773.
3
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Antimicrob Agents Chemother. 1976 Jun;9(6):988-93. doi: 10.1128/AAC.9.6.988.
4
In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.
J Infect Dis. 1977 Mar;135 Suppl:S49-53. doi: 10.1093/infdis/135.supplement.s49.
7
In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.
Antimicrob Agents Chemother. 1976 Aug;10(2):253-7. doi: 10.1128/AAC.10.2.253.
8
In vitro susceptibility studies with josamycin and erythromycin.
Antimicrob Agents Chemother. 1976 Mar;9(3):546-8. doi: 10.1128/AAC.9.3.546.
9
Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.
Antimicrob Agents Chemother. 1974 Mar;5(3):272-5. doi: 10.1128/AAC.5.3.272.
10
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
Antimicrob Agents Chemother. 1987 Feb;31(2):343-5. doi: 10.1128/AAC.31.2.343.

引用本文的文献

2
In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.
Antimicrob Agents Chemother. 1978 Sep;14(3):493-4. doi: 10.1128/AAC.14.3.493.
3
In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
Antimicrob Agents Chemother. 1978 Aug;14(2):274-6. doi: 10.1128/AAC.14.2.274.
4
In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.
Antimicrob Agents Chemother. 1979 Jul;16(1):106-8. doi: 10.1128/AAC.16.1.106.

本文引用的文献

1
Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.
Antimicrob Agents Chemother. 1974 Mar;5(3):272-5. doi: 10.1128/AAC.5.3.272.
2
Prosthetic valvular endocarditis. A 12-year review.
Circulation. 1973 Jun;47(6):1319-26. doi: 10.1161/01.cir.47.6.1319.
3
Antibiotic sensitivity testing. Report of an international collaborative study.
Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217:Suppl 217:1+.
4
Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.
Antimicrob Agents Chemother. 1976 Feb;9(2):350-1. doi: 10.1128/AAC.9.2.350.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验